Genesco (GCO) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
22 Jan, 2026Executive summary
Q2 FY25 net sales reached $525 million, flat to slightly up year-over-year, exceeding expectations due to Journeys' strong performance and early back-to-school demand, while Schuh and Johnston & Murphy faced headwinds from tough comparisons and market softness.
Digital business grew 8%, now representing 22% of retail sales, and cost optimization plus store footprint reduction supported improved bottom-line results.
Inventory was well managed, down 8% year-over-year, and the store base was reduced by 61 stores year-over-year, with 12 closures in Q2.
Net loss narrowed to $10 million ($0.91 per share GAAP, $0.83 non-GAAP), reflecting improved operating margin and absence of prior year goodwill impairment.
Journeys saw positive comps in July and August, driven by refreshed product assortment and enhanced consumer experiences, while Schuh and Johnston & Murphy were pressured by market conditions but benefited from new products and digital strength.
Financial highlights
Consolidated revenue for Q2 was $525 million, with gross margin at 46.8% (down from 47.7% last year) and adjusted operating loss of $9.3 million, an improvement from $10 million loss last year.
Selling and administrative expenses were 48.6% of sales, down from 49.6% last year, aided by cost initiatives and store closures.
Adjusted diluted loss per share was $0.83 versus $0.85 last year; net cash used in operating activities improved to $6 million for the first six months.
Inventory turnover improved with an 8% year-over-year inventory reduction.
Repurchased 382,000 shares for $9.3 million; $42.8 million remains on authorization.
Outlook and guidance
FY25 non-GAAP EPS guidance is $0.60–$1.00, with sales expected to decrease 1%–2%, or flat to down 1% excluding the 53rd week.
Adjusted gross margin rates for the year expected to be down 10–20 basis points; SG&A expenses flat to 20 basis points leverage.
Q3 comps expected up low single digits, with sales down slightly due to calendar shift.
FY25 CapEx projected at $52–$57 million, focused on omni-channel, IT, and store investments.
Latest events from Genesco
- Proxy contest seeks board refreshment and governance reform, urging votes for two independent nominees.GCO
Proxy filing18 Jun 2026 - Board urges support for its nominees, citing strong results and risks from activist candidates.GCO
Proxy filing16 Jun 2026 - Shareholders will vote on board nominees, executive pay, an equity plan, and auditor ratification.GCO
Proxy filing15 Jun 2026 - Board recommends voting for its nominees and proposals, highlighting governance, pay, and ESG.GCO
Proxy filing11 Jun 2026 - Sales and margins improved, FY27 EPS outlook raised, and a major cost savings program launched.GCO
Q1 202711 Jun 2026 - Proxy contest seeks board refreshment, opposes executive pay, and urges auditor ratification.GCO
Proxy filing8 Jun 2026 - Board urges support for its nominees, executive pay, equity plan, auditor, and ESG priorities.GCO
Proxy filing3 Jun 2026 - Q4 saw 7% revenue growth and strong comps; 2027 outlook targets margin and EPS gains.GCO
Q4 20266 Mar 2026 - Strong holiday comps and strategic initiatives drive optimism for sustained growth.GCO
28th Annual ICR Conference 202512 Jan 2026